Hyun Jung Kim, MD

Hyun Jung Kim, MD is a child and adolescent psychiatrist, specializing in psychosis-risk syndromes and early psychosis. After completing psychiatry residency at Duke University and a child and adolescent psychiatry fellowship at Harvard Medical School/Boston Children’s Hospital, Dr. Kim joined Yale School of Medicine, where she co-founded the Transitional Age Youth (TAY, ages 15-25) program. She also developed deep expertise in college mental health through collaborations with leading universities, including Duke, Yale, Harvard, and MIT. Her clinical excellence, commitment to education, and scholarly contributions have been recognized with numerous local and national awards and leadership appointments. In 2017, Dr. Kim joined McLean Hospital and Harvard Medical School, where her work has increasingly focused on psychosis-risk syndromes in transitional age youth. She co-founded and currently directs psychiatric training and community outreach for McLean’s Support, Treatment, and Resilience (STAR) Program, which focuses on young people who are at risk for developing psychotic conditions. Currently, Dr. Kim’s work centers on two key areas: elucidating the relationship between psychosis and substance use—particularly psychedelics and cannabis—and accelerating access to early psychosis care.

Education & Training

• Fellowship: Children's Hospital, Child & Adolescent Psychiatry, 2014
• Residency: Duke University Hospital, Psychiatry, 2012
• Medical Education: Catholic Medical College, Doctor of Medicine, 2003

Board Certifications

• Psychiatry, American Board of Psychiatry and Neurology
• Child and Adolescent Psychiatry, American Board of Psychiatry and Neurology

Languages Spoken

• English

Age Group Treated

• Pediatrics
• Adolescents
• Adults